Search Results
Search for other papers by Kim K B Clemmensen in
Google Scholar
PubMed
Search for other papers by Jonas S Quist in
Google Scholar
PubMed
Search for other papers by Dorte Vistisen in
Google Scholar
PubMed
Danish Diabetes Academy, Odense, Denmark
Search for other papers by Daniel R Witte in
Google Scholar
PubMed
Search for other papers by Anna Jonsson in
Google Scholar
PubMed
Search for other papers by Oluf Pedersen in
Google Scholar
PubMed
Search for other papers by Torben Hansen in
Google Scholar
PubMed
Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Search for other papers by Torsten Lauritzen in
Google Scholar
PubMed
National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark
Search for other papers by Marit E Jørgensen in
Google Scholar
PubMed
Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Signe Torekov in
Google Scholar
PubMed
Search for other papers by Kristine Færch in
Google Scholar
PubMed
shown as means ( s.d. ) or median (quartile 1, quartile 3). CRF, cardiorespiratory fitness; GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-like peptide 1; IFG, impaired fasting glucose; i-IFG, isolated IFG; IGT, impaired glucose
Search for other papers by David S Mathiesen in
Google Scholar
PubMed
Department of Medicine, Gentofte and Herlev Hospital, University of Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Gentofte, Denmark
Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed
Search for other papers by Katrine B Hansen in
Google Scholar
PubMed
Search for other papers by Anders E Junker in
Google Scholar
PubMed
Search for other papers by Astrid Plamboeck in
Google Scholar
PubMed
Search for other papers by Signe Harring in
Google Scholar
PubMed
Search for other papers by Thomas Idorn in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Center for Cancer and Organ Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Mads Hornum in
Google Scholar
PubMed
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Search for other papers by Anna E Jonsson in
Google Scholar
PubMed
Search for other papers by Torben Hansen in
Google Scholar
PubMed
Novartis Healthcare A/S, Copenhagen, Denmark
Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Asger Lund in
Google Scholar
PubMed
Department of Medicine, Gentofte and Herlev Hospital, University of Copenhagen, Denmark
Novartis Healthcare A/S, Copenhagen, Denmark
Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
effect is mediated by the two gut hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) ( 6 ). These hormones are secreted from enteroendocrine K and L cells, situated in the intestinal mucosa, in response to
Department of Clinical Physiology and Nuclear Medicine, Bispebjerg and Frederiksberg Hospital, University Hospital of Copenhagen, Copenhagen, Denmark
Search for other papers by Meena Asmar in
Google Scholar
PubMed
Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
Search for other papers by Ali Asmar in
Google Scholar
PubMed
Search for other papers by Lene Simonsen in
Google Scholar
PubMed
Department of Geriatrics, Bispebjerg and Frederiksberg Hospital, University Hospital of Copenhagen, Copenhagen, Denmark
Search for other papers by Flemming Dela in
Google Scholar
PubMed
Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Juul Holst in
Google Scholar
PubMed
Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Bülow in
Google Scholar
PubMed
.1111/j.1748-1716.1990.tb08932.x ) 1973329 7 Asmar M Simonsen L Madsbad S Stallknecht B Holst JJ Bulow J . Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean
Search for other papers by Henri Honka in
Google Scholar
PubMed
Department of Gastroenterology, Turku University Hospital, Turku, Finland
Search for other papers by Jukka Koffert in
Google Scholar
PubMed
Search for other papers by Saila Kauhanen in
Google Scholar
PubMed
Search for other papers by Nobuyuki Kudomi in
Google Scholar
PubMed
Search for other papers by Saija Hurme in
Google Scholar
PubMed
Search for other papers by Andrea Mari in
Google Scholar
PubMed
Search for other papers by Andreas Lindqvist in
Google Scholar
PubMed
Search for other papers by Nils Wierup in
Google Scholar
PubMed
Search for other papers by Riitta Parkkola in
Google Scholar
PubMed
Search for other papers by Leif Groop in
Google Scholar
PubMed
Department of Endocrinology, Turku University Hospital, Turku, Finland
Search for other papers by Pirjo Nuutila in
Google Scholar
PubMed
incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) account for the gut-derived amplification of insulin secretion ( 4 ). In addition to the effect on pancreatic islets, we ( 5 ) and others ( 6 ) have
Search for other papers by Amalie R Lanng in
Google Scholar
PubMed
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Lærke S Gasbjerg in
Google Scholar
PubMed
Search for other papers by Natasha C Bergmann in
Google Scholar
PubMed
Search for other papers by Sigrid Bergmann in
Google Scholar
PubMed
Search for other papers by Mads M Helsted in
Google Scholar
PubMed
Search for other papers by Matthew P Gillum in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Bolette Hartmann in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Steno Diabetes Center Copenhagen, Gentofte, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Gentofte, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
). Likewise, the effect of alcohol on the secretion of the gut-derived insulinotropic incretin hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) remains unclear ( 6 , 11 , 12 ). Recently, alcohol was shown to
Search for other papers by Sakina H Bharmal in
Google Scholar
PubMed
Search for other papers by Wandia Kimita in
Google Scholar
PubMed
Search for other papers by Juyeon Ko in
Google Scholar
PubMed
Search for other papers by Maxim S Petrov in
Google Scholar
PubMed
centrifuged at 4000 g for5.5 min at 4°C, plasma separated, aliquoted, and stored at −80°C for future analyses.Amylin, C-peptide, glucagon, glucose-dependent insulinotropic peptide (GIP), glucagon-like peptide-1 (GLP-1), insulin, pancreatic polypeptide, and
Department of Medicine, Department of Biomedical Sciences, Department of Endocrinology, Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Kildegårdsvej 28, DK-2900 Hellerup, Denmark
Search for other papers by David P Sonne in
Google Scholar
PubMed
Department of Medicine, Department of Biomedical Sciences, Department of Endocrinology, Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Kildegårdsvej 28, DK-2900 Hellerup, Denmark
Search for other papers by Asger Lund in
Google Scholar
PubMed
Search for other papers by Jens Faber in
Google Scholar
PubMed
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Department of Medicine, Department of Biomedical Sciences, Department of Endocrinology, Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Kildegårdsvej 28, DK-2900 Hellerup, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Department of Medicine, Department of Biomedical Sciences, Department of Endocrinology, Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Kildegårdsvej 28, DK-2900 Hellerup, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
i) whether i.v. glucose per se could affect thyroid function parameters and ii) whether any changes could be elicited by infusion of the gastrointestinal hormones glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP1
Department of Endocrinology, Jiading Branch of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Lizhi Zhang in
Google Scholar
PubMed
Search for other papers by Jinwei He in
Google Scholar
PubMed
Search for other papers by Xiang Sun in
Google Scholar
PubMed
Search for other papers by Dongyue Pang in
Google Scholar
PubMed
Search for other papers by Jingjing Hu in
Google Scholar
PubMed
Search for other papers by Bo Feng in
Google Scholar
PubMed
A Boni S Flatt PR Irwin N Chappard D . Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption . Bone 2016 91 102 – 112 . ( https://doi.org/10.1016/j.bone.2016.07.014 ) 11
Search for other papers by L Ahlkvist in
Google Scholar
PubMed
Search for other papers by K Brown in
Google Scholar
PubMed
Search for other papers by B Ahrén in
Google Scholar
PubMed
of glucose-dependent insulinotropic polypeptide from primary murine K cells . Diabetologia 2009 52 289 – 298 . ( doi:10.1007/s00125-008-1202-x ). 39 Christensen M Vedtofte L Holst JJ Vilsboll T Knop FK . Glucose-dependent
Search for other papers by Kim K B Clemmensen in
Google Scholar
PubMed
Search for other papers by Jonas S Quist in
Google Scholar
PubMed
Search for other papers by Dorte Vistisen in
Google Scholar
PubMed
Danish Diabetes Academy, Odense, Denmark
Search for other papers by Daniel R Witte in
Google Scholar
PubMed
Search for other papers by Anna Jonsson in
Google Scholar
PubMed
Search for other papers by Oluf Pedersen in
Google Scholar
PubMed
Search for other papers by Torben Hansen in
Google Scholar
PubMed
Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Search for other papers by Torsten Lauritzen in
Google Scholar
PubMed
National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark
Search for other papers by Marit E Jørgensen in
Google Scholar
PubMed
Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Signe Torekov in
Google Scholar
PubMed
Search for other papers by Kristine Færch in
Google Scholar
PubMed
.026 Estimates are per 1 h increase in fasting duration. Linear regression models. GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-like peptide 1; rAUC 0–30 , relative early response; rAUC 0–120 , relative total response.